In the News
Recent Control Investments
Past Control Investments
GEM Global Emerging Markets
Global Emerging Markets (“GEM”) is a $3.4 billion alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world.
Global Emerging Markets Announces Initial Investment in Relief Therapeutics SA
GEM Executes Investment in Mondo TV for EUR 35 Million
WISeKey Announces at the World Economic Forum in Davos That It Has Secured a CHF 60 Million Equity Financing Facility from a Consortium of International Institutional Investors Led by GEM
YuuZoo Corporation secures SG$30 million Capital Commitment from GEM Global
THERAMetrics Holding AG and RELIEF THERAPEUTICS SA Have Signed a Binding Agreement to Combine Their Two Companies
Tyme Technologies, Inc. Receives FDA Acceptance of Investigational New Drug Application for Oncology Drug Candidate, SM-88
Save the Planet. Eat Ugly.
GEM commits investment worth VND 1,700 billion in HAG